As of today (2024-04-27), Vifor Pharma AG's share price is CHF165.55.
Vifor Pharma AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF4.75. Hence, Vifor Pharma AG's Price-to-Free-Cash-Flow Ratio for today is 34.86.
The historical rank and industry rank for Vifor Pharma AG's Price-to-Free-Cash-Flow or its related term are showing as below:
LTS:0RPD'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 22.83 Med: 34.42 Max: 814.52
Current: 37.02
During the past 13 years, Vifor Pharma AG's highest Price-to-Free-Cash-Flow Ratio was 814.52. The lowest was 22.83. And the median was 34.42.
LTS:0RPD's Price-to-Free-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 21.8
vs LTS:0RPD: 37.02
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Vifor Pharma AG was 658.10% per year.
During the past 13 years, Vifor Pharma AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 242.00% per year. The lowest was -67.30% per year. And the median was 7.15% per year.
Vifor Pharma AG Price-to-Free-Cash-Flow Historical Data
The historical data trend for Vifor Pharma AG's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vifor Pharma AG's Price-to-Free-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vifor Pharma AG's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Vifor Pharma AG's Price-to-Free-Cash-Flow falls into.
Vifor Pharma AG Price-to-Free-Cash-Flow Calculation
Vifor Pharma AG's Price-to-Free-Cash-Flow ratio for today is calculated as
Vifor Pharma AG's Share Price of today is CHF165.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vifor Pharma AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF4.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Vifor Pharma AG (LTS:0RPD) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Vifor Pharma AG Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Vifor Pharma AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0RPD has been successfully added to your 